Chiromics Strikes Deals With BMS, GSK | Chemical & Engineering News
Volume 90 Issue 47 | p. 19 | Concentrates
Issue Date: November 19, 2012

Chiromics Strikes Deals With BMS, GSK

Department: Business
Keywords: pharmaceuticals, biotech, compound libraries

Chiromics has snagged two big pharma partners. In one deal, Bristol-Myers Squibb gains access to Chiromics’ chemical library and a proprietary collection of compounds. The two have also entered a screening collaboration for the discovery of novel small molecules. With GlaxoSmithKline, Chiromics will look for small molecules against certain targets using the biotech firm’s compound collection and screening technology. Chiromics was founded in 2009 with technology developed in the labs of Princeton University chemist David W. C. MacMillan.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment